Karl Max Einhäupl

MDC bids farewell to Charité’s head Karl Max Einhäupl and welcomes his successor Heyo Kroemer, lauding fair collaboration

As Karl Max Einhäupl steps down as Chairman of the Charité’s Executive Board, Thomas Sommer, interim Scientific Director of the MDC, honors Einhäupl’s achievements and applauds him for the excellent and equitable collaboration. Sommer wishes the Charité’s new head, Heyo Kroemer, the very best and much success in his new position.

Karl Max Einhäupl

“Karl Max Einhäupl has done a great deal for the Charité, for Berlin, and most of all for patients,” says Sommer, with regard to Einhäupl’s farewell. “Einhäupl has left his mark on the Charité. Despite enormous pressure to cut costs, he modernized the university hospital and raised its international profile. That is one of his greatest achievements,” says Sommer. Sommer lauds the fruitful collaboration and the good exchange between the Charité and the Max Delbrück Center for Molecular Medicine (MDC) over the past years. “Our cooperation was and is characterized by good, collegial, and respectful interactions – that is thanks to Karl Max Einhäupl’s fair and uncomplicated leadership and to his great personal commitment. He has always focused on the common goal of advancing medical science. For that we extend our most heartfelt gratitude to Prof. Einhäupl,” adds Sommer.

Our cooperation was and is characterized by good, collegial, and respectful interactions.
Thomas Sommer
Thomas Sommer Scientific Director of the MDC (interim)

After eleven years in office, Einhäupl will on September 1 be handing over the reins of Executive Board Chairman to Heyo Kroemer, the current head of University Medical Center Göttingen. Sommer wishes the new head of the Charité’s board much success and all the best in his new position. “The Charité is one of the most well-known hospitals in Europe, if not the world. It can count itself fortunate to have such an experienced manager at its helm. I congratulate Heyo Kroemer, with whom I’ve collaborated well in the past, and wish him a good start and every success in tackling the challenges that lie ahead. I look forward to working together with him,” says Sommer.

About the cooperation between the Charité and the MDC

The MDC and the Charité work together in many ways. The MDC’s most important university partner for translational research is the Charité, which serves as the medical school of both Freie Universität Berlin und Humboldt-Universität zu Berlin (HU). MDC professors teach at both universities. In collaboration with the MDC and the Charité, HU founded the Integrative Research Institute (IRI) for the Life Sciences in 2013. It pursues cutting-edge biomedical research with an interdisciplinary and inter-institutional approach.

Since 2007, the MDC and the Charité have jointly run the Experimental and Clinical Research Center (ECRC), a center for translational medicine on the Buch campus. At the ECRC , researchers and clinicians work closely together on joint projects. In addition, a clinical training program has been established for young clinicians who wish to train in one of the MDC laboratories. The ECRC also houses specialized outpatient clinics of the Charité. MDC researchers work closely together with clinicians in the university outpatient clinics and consultation rooms on the campus in Berlin-Buch.

In July 2019, a consortium of three major Berlin universities and the Charité was awarded elite status in the Excellence Initiative competition of the German government. The MDC is part of the NeuroCure Cluster of Excellence, and participates in the Berlin Mathematics Research Center MATH+. The Center is also involved in a number of graduate schools.

In recent years, the MDC and the Charité have jointly laid the foundation for Berlin Institute of Health (BIH). The BIH is to become – alongside the university hospital and the medical faculty – the third pillar of the Charité. The MDC will be a privileged partner of the BIH. The BIH is erecting a new central research facility on the Berlin-Buch research campus, in the immediate vicinity of the MDC. It will carry the name of the Berlin pediatrician Käthe Beutler, who was forced to flee Germany in 1935.

Press Contact

Jutta Kramm
Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)  
Head of the Communications Department

Phone.: +49 (0)30-9406-2140

The Max Delbrück Center for Molecular Medicine (MDC)


The Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) was founded in Berlin in 1992. It is named for the German-American physicist Max Delbrück, who was awarded the 1969 Nobel Prize in Physiology and Medicine. The MDC's mission is to study molecular mechanisms in order to understand the origins of disease and thus be able to diagnose, prevent and fight it better and more effectively. In these efforts the MDC cooperates with the Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) as well as with national partners such as the German Center for Cardiovascular Research and numerous international research institutions. More than 1,600 staff and guests from nearly 60 countries work at the MDC, just under 1,300 of them in scientific research. The MDC is funded by the German Federal Ministry of Education and Research (90 percent) and the State of Berlin (10 percent), and is a member of the Helmholtz Association of German Research Centers. www.mdc-berlin.de